<html>
  <head></head>
  <body>
    <div id="title">
      <h2>"Point in Time" Regulation Content</h2>
      <h4>
        <em> Pharmacy Operations and Drug Scheduling Act </em>
      </h4>
      <h3 style="line-height: 110%">Drug Schedules Regulation</h3>
      <h3>B.C. Reg. 9/98</h3>
    </div>
    <table cellpadding="3" cellspacing="0" class="tablestyle3">
      <tbody>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">
            Dimethyl sulfoxide, for veterinary use or when sold for the
            treatment of interstitial cystitis or scleroderma in humans
          </td>
        </tr>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">
            Dopamine and its salts, when sold for administration by injection
          </td>
        </tr>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">Dutasteride</td>
        </tr>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">
            Gold and its salts and derivatives, when sold for administration by
            injection
          </td>
        </tr>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">
            Ibuprofen and its salts except when sold for oral administration in
            a concentration of 400 mg or less per dosage unit
          </td>
        </tr>
        <tr>
          <td align="right" valign="top">3</td>
          <td valign="top">
            Ibuprofen and its salts containing 400 mg or less per oral dosage
            unit (when sold in package sizes exceeding 18 000 mg)
          </td>
        </tr>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">
            Levocarnitine and its salts and derivatives, when sold for the
            treatment of primary or secondary levocarnitine deficiency
          </td>
        </tr>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">
            L-Tryptophan, when sold
            <br />
            (a) for human use in oral dosage form at a concentration of more
            than 220 mg per dosage unit or per daily dose, as a single
            ingredient or in combination with other ingredients, or
            <br />
            (b) for human or veterinary use as a single ingredient intended for
            any route of administration other than oral
          </td>
        </tr>
        <tr>
          <td align="right" valign="top">1</td>
          <td valign="top">
            Uracil and its salts, when sold for the treatment of cancer
          </td>
        </tr>
      </tbody>
    </table>
  </body>
</html>
